Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,526.80
(
0.55%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
107.07
(
-1.93%
)
Bitcoin
69,828.25
(
1.19%
)
News Focus
News Focus
Post# of 257364
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 109207

Thursday, 11/18/2010 3:13:20 PM

Thursday, November 18, 2010 3:13:20 PM

Post# of 257364

We’ll find out soon if Denosumab does



There is at least some chance the EXEL drug will make Denosumab superfluous in this indication. But also some chance I suppose that the combination would be good.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today